We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$70.7B
AUM Growth
-$13.8B
Cap. Flow
-$8.71B
Cap. Flow %
-12.32%
Top 10 Hldgs %
10.57%
Holding
4,619
New
441
Increased
1,316
Reduced
2,164
Closed
637

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$777M
2
META icon
Meta Platforms (Facebook)
META
+$752M
3
TSLA icon
Tesla
TSLA
+$627M
4
CVX icon
Chevron
CVX
+$528M
5
SHOP icon
Shopify
SHOP
+$439M

Sector Composition

Rank Sector Weight
1 Healthcare 19.4%
2 Technology 18.51%
3 Consumer Staples 10.15%
4 Consumer Discretionary 9.67%
5 Financials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBEF icon
3201
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.35B
$308K ﹤0.01%
+9,200
New +$328K
SPGP icon
3202
Invesco S&P 500 GARP ETF
SPGP
$2.3B
$307K ﹤0.01%
+4,100
New +$341K
YRD
3203
Yiren Digital
YRD
$110M
$307K ﹤0.01%
286,965
-32,700
-10% -$41.1K
PNT
3204
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$307K ﹤0.01%
+39,700
New +$337K
IYH icon
3205
iShares US Healthcare ETF
IYH
$3.48B
$304K ﹤0.01%
+6,000
New +$324K
AHG
3206
Akso Health Group
AHG
$1.14B
$303K ﹤0.01%
334,298
-121,150
-27% -$129K
ARDX icon
3207
Ardelyx
ARDX
$1.22B
$303K ﹤0.01%
254,249
+45,256
+22% +$43.1K
LDUR icon
3208
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
$303K ﹤0.01%
+3,200
New +$306K
MSBI icon
3209
Midland States Bancorp
MSBI
$709M
$302K ﹤0.01%
12,800
-23,008
-64% -$594K
ARAV
3210
DELISTED
Aravive, Inc. Common Stock
ARAV
$302K ﹤0.01%
369,829
-5,116
-1% -$4.4K
BBUC
3211
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.16B
$301K ﹤0.01%
13,600
-1,300
-9% -$32K
UDMY
3212
DELISTED
Udemy
UDMY
$300K ﹤0.01%
24,800
+14,100
+132% +$188K
STER
3213
DELISTED
Sterling Check Corp. Common Stock
STER
$300K ﹤0.01%
+17,000
New +$338K
FNDC icon
3214
Schwab Fundamental International Small Company Index ETF
FNDC
$3.13B
$299K ﹤0.01%
10,980
-3,120
-22% -$95K
SND icon
3215
Smart Sand
SND
$187M
$299K ﹤0.01%
191,767
+88,267
+85% +$168K
LYEL icon
3216
Lyell Immunopharma
LYEL
$363M
$298K ﹤0.01%
2,035
-475
-19% -$64.3K
YI
3217
111 Inc
YI
$34.2M
$298K ﹤0.01%
11,135
+230
+2% +$6.2K
APTO
3218
DELISTED
Aptose Biosciences, Inc.
APTO
$296K ﹤0.01%
1,104
+133
+14% +$45.8K
ARMP icon
3219
Armata Pharmaceuticals
ARMP
$171M
$295K ﹤0.01%
69,796
-10,200
-13% -$41.1K
IRON icon
3220
Disc Medicine
IRON
$3B
$295K ﹤0.01%
5,995
-3,358
-36% -$158K
FRPH icon
3221
FRP Holdings
FRPH
$410M
$294K ﹤0.01%
10,800
-2,000
-16% -$58.3K
RSPT icon
3222
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.78B
$294K ﹤0.01%
13,000
+1,000
+8% +$25.6K
LTCH
3223
DELISTED
Latch, Inc. Common Stock
LTCH
$294K ﹤0.01%
308,100
-378,100
-55% -$434K
TPG icon
3224
TPG
TPG
$7.68B
$292K ﹤0.01%
10,500
-201,400
-95% -$5.82M
CBIO
3225
Crescent Biopharma
CBIO
$588M
$290K ﹤0.01%
5,263
-401
-7% -$28.8K

Similar funds

Renaissance Technologies's Q3 2022 Portfolio in Review

As of Q3 2022, Renaissance Technologies held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class A worth $498M.

  • Renaissance Technologies's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
  • Renaissance Technologies added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
  • Renaissance Technologies's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
  • Renaissance Technologies fully exited Shopify in Q3 2022, selling an estimated $439M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
  • Renaissance Technologies opened 441 new positions and closed 637 in Q3 2022.
  • Renaissance Technologies's portfolio value fell 16% quarter-over-quarter to $70.7B.

Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.